Contact this trialFirst, we need to learn more about you.
Ruxolitinib Continuation for Cancer
Recruiting1 awardPhase 2
Houston, Texas
This trial is for subjects who have completed an Incyte-sponsored study of ruxolitinib and will continue receiving the drug, ruxolitinib plus cancer therapy, or just cancer therapy. The purpose is to monitor safety and adverse events.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service